We are pleased to share moments from our recent Central European Lung Cancer Forum 2024 that was held in Vienna. The event featured enlightening presentations and engaging discussions, fostering collaboration and innovation within our community. Thank you to all who attended and contributed.

Check out the full article about our project: https://ccc.meduniwien.ac.at/en/about-us/news/news/sclc/

"...The BIOSMALL project is a staff exchange program supporting international and interdisciplinary mobility for scientists in the field of small cell lung cancer (SCLC) research. The consortium of researchers from Austria, Sweden, Germany, Hungary and the Netherlands has been awarded € 897.000 funding to continue their internationally recognized works on the molecular subclassification of SCLC."

🔬 The importance of this project: 

Small Cell Lung Cancer (SCLC) poses a significant challenge in oncology, with limited treatment options and poor prognosis for patients, with a 5-year survival rate under 7%. It represents about 13%–15% of lung cancer cases; however, SCLC still lacks the benefit of personalized and effective therapies that have transformed outcomes in other types of cancer.